Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 781-790 of 9364

Page
per page
  1. PF-4989216
    B5948 PF-4989216
    Summary: Selective oral PI3K inhibitor
      Soluble in DMSO
  2. BG45
    B5949 BG45
    Summary: Novel HDAC3-selective inhibitor
      Soluble in DMSO
  3. AZD8186
    B5950 AZD8186
    Target: PI3K
    Summary: Potent and selective inhibitor of PI3Kβ and PI3Kδ
      insoluble in H2O; insoluble in EtOH; ≥45.7 mg/mL
  4. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).
      insoluble in EtOH; ≥10.62 mg/mL
  5. Dasatinib Monohydrate
    B5954 Dasatinib Monohydrate
    Target: PDGFR|c-Kit|Bcr-Abl|Src
    Summary: Inhibitor of ABL, SRC, KIT, PDGFR, and other tyrosine kinases.
      ≥25.3 mg/mL
  6. Oltipraz
    B5958 Oltipraz
    Summary: Nrf2 activator;An antischistosomal agent
      ≥22.6 mg/mL
  7. PF-03394197(Oclacitinib)
    B5960 PF-03394197(Oclacitinib)
    Summary: Novel Janus kinase inhibitor
      ≥33.7 mg/mL
  8. AZD3759
    B5962 AZD3759
    Summary: EGFR inhibitor，oral active
      ≥23 mg/mL
  9. 7-Ethoxyresorufin
    B5963 7-Ethoxyresorufin
    Target: Cytochrome P450 (CYP450)
    Summary: Specific subtrate of CYP1A
      Soluble in DMSO
  10. MnTBAP Chloride
    B5964 MnTBAP Chloride
    Target: Peroxynitrite
    Summary: Cell-permeable superoxide dismutase mimetic
      ≥25.4 mg/mL

Items 781-790 of 9364

Page
per page